Imojev Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Live, attenuated, recombinant Japanese encephalitis virus (propagated in Vero cells)

Indications/Uses

Prophylaxis of Japanese encephalitis in individuals ≥9 mth.

Click to view Imojev detailed prescribing information

Dosage/Direction for Use

Primary immunization Childn ≥9 mth 0.5 mL single SC inj. Booster dose Adult ≥18 yr No need for booster dose up to 5 yr after 1st vaccination. Childn 9 mth-17 yr 12-24 mth after primary vaccination.

Click to view Imojev detailed prescribing information

Overdosage

View Imojev overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to the vaccine or after previous inj. Postpone vaccination in case of febrile or acute disease. Congenital or acquired immune deficiency impairing cellular immunity including immunosuppressive therapies eg, chemotherapy & high-dose systemic corticosteroids. Symptomatic or asymptomatic HIV-infected patient. Pregnancy & lactation.

Click to view Imojev detailed prescribing information

Special Precautions

History of serious or severe reaction w/in 48 hr of previous vaccine inj. Not to be inj intravascularly. Treatment w/ high-dose systemic corticosteroids given ≥14 days should be administered for ≥1 mth before vaccination. Not recommended in childn <9 mth.

Click to view Imojev detailed prescribing information

Use In Pregnancy & Lactation

Click to view Imojev detailed prescribing information

Adverse Reactions

Fatigue, malaise, inj site pain; headache; myalgia. Feeling hot, chills, inj site erythema, pruritus, swelling & bruising; dizziness; arthralgia; diarrhoea, nausea, abdominal pain, vomiting; pharyngolaryngeal pain, dyspnea, rhinorrhea, cough, wheezing, nasal congestion; rash. Childn: Somnolence; inconsolable crying; loss of appetite.

Click to view Imojev detailed prescribing information

Drug Interactions

Vaccination must not be performed w/in 6 wk & not w/in 3 mth of Ig inj or Ig-containing blood products eg, blood or plasma to avoid neutralisation of attenuated viruses.

Click to view Imojev detailed prescribing information

Storage

View Imojev storage conditions for details to ensure optimal shelf-life.

Description

View Imojev description for details of the chemical structure and excipients (inactive components).

Action

View Imojev mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BA03 - encephalitis, Japanese, live attenuated ; Belongs to the class of encephalitis viral vaccines.

Regulatory Classification

Presentation/Packing

Form

Imojev vaccine (inj) (vial)

Packing/Price

0.5 mL x 1's

Imojev

vaccine, japanese encephalitis

Manufacturer:

sanofi pasteur

Distributor:

Zuellig Pharma